Skip to main content
SpringerLink
Log in

Neuropeptide Processing

  • Chapter
Proteases In The Brain

Part of the book series: Proteases In Biology and Disease ((PBAD,volume 3))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  • Ahmad S, Ward PE, 1990, Role of aminopeptidase activity in the regulation of the pressor activity of circulating angiotensins. J Pharmacol Exp Ther. 252: 643–650.

    CAS  PubMed  Google Scholar 

  • Albiston AL, McDowall SG, Matsacos D, Sim P, Clune E, Mustafa T, Lee J, Mendelsohn FA, Simpson RJ, Connolly LM, Chai SY, 2001, Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase. J Biol Chem. 276: 48623–48626.

    Article  CAS  PubMed  Google Scholar 

  • Amara SG, Jonas V, Rosenfeld MG, Ong ES, Evans RM, 1982, Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature. 298: 240–244.

    Article  CAS  PubMed  Google Scholar 

  • Ardaillou R, Chansel D, 1997, Synthesis and effects of active fragments of angiotensin II. Kidney Int. 52: 1458–1468.

    CAS  PubMed  Google Scholar 

  • Argyropoulos SV, Nutt DJ, 2000, Substance P antagonists: novel agents in the treatment of depression. Expert Opin Investig Drugs. 9: 1871–1875.

    Article  CAS  PubMed  Google Scholar 

  • Baldock PA, Sainsbury A, Couzens M, Enriquez RF, Thomas GP, Gardiner EM, Herzog H, 2002, Hypothalamic Y2 receptors regulate bone formation. J Clin Invest. 109: 915–921.

    Article  CAS  PubMed  Google Scholar 

  • Barnes PJ, 1986, Asthma as an axon reflex. Lancet. 1: 242–245.

    CAS  PubMed  Google Scholar 

  • Barnes PJ, Baraniuk JN, Belvisi MG, 1991, Neuropeptides in the respiratory tract. Part I. Am Rev Respir Dis. 144: 1187–1198.

    CAS  PubMed  Google Scholar 

  • Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR, 2002, Gut hormone PYY(3-36) physiologically inhibits food intake. Nature. 418: 650–654.

    Article  CAS  PubMed  Google Scholar 

  • Becu-Villalobos D, Lacau-Mengido IM, Thyssen SM, Diaz-Torga GS, Libertun C, 1994, Effects of LHRH and ANG II on prolactin stimulation are mediated by hypophysial AT1 receptor subtype. Am J Physiol. 266: E274–278.

    Google Scholar 

  • Berman Y, Ageyeva L, Veksler B, Wood D, Devi LA, 1999, Dynorphin A processing enzyme: tissue distribution, isolation, and characterization. J Biochem (Tokyo). 125: 641–647.

    CAS  Google Scholar 

  • Blair-West JR, Carey KD, Denton DA, Madden LJ, Weisinger RS, Shade RE, 2001, Possible contribution of brain angiotensin III to ingestive behaviors in baboons. Am J Physiol Regul Integr Comp Physiol. 281: R1633–1636.

    Google Scholar 

  • Bonetto V, Jornvall H, Andersson M, Renlund S, Mutt V, Sillard R, 1999, Isolation and characterization of sulphated and nonsulphated forms of cholecystokinin-58 and their action on gallbladder contraction. Eur J Biochem. 264: 336–340.

    Article  CAS  PubMed  Google Scholar 

  • Brain SD, Williams TJ, Tippins JR, Morris HR, MacIntyre I, 1985, Calcitonin gene-related peptide is a potent vasodilator. Nature. 313: 54–56.

    Article  CAS  PubMed  Google Scholar 

  • Brantl V, Gramsch C, Lottspeich F, Henschen A, Jaeger KH, Herz A, 1985, Novel opioid peptides derived from mitochondrial cytochrome b: cytochrophins. Eur J Pharmacol. 111: 293–294.

    Article  CAS  PubMed  Google Scholar 

  • Burger E, 1988, Peptide hormones and neuropeptides. Proteolytic processing of the precursor regulatory peptides. Arzneimittelforschung. 38: 754–761.

    CAS  PubMed  Google Scholar 

  • Camargo AC, Oliveira EB, Toffoletto O, Metters KM, Rossier J, 1987, Brain endooligopeptidase A, a putative enkephalin converting enzyme. J Neurochem. 48: 1258–1263.

    CAS  PubMed  Google Scholar 

  • Camelo D, Arboleda G, Yunis JJ, Pardo R, Arango G, Solano E, Lopez L, Hedmont D, Arboleda H, 2004, Angiotensin-converting enzyme and alpha-2-macroglobulin gene polymorphisms are not associated with Alzheimer’s disease in Colombian patients. J Neurol Sci. 218:47–51.

    CAS  Google Scholar 

  • Campbell DJ, Kladis A, Duncan AM, 1993, Bradykinin peptides in kidney, blood, and other tissues of the rat. Hypertension. 21: 155–165.

    CAS  PubMed  Google Scholar 

  • Canaff L, Bennett HP, Hendy GN, 1999, Peptide hormone precursor processing: getting sorted? Mol Cell Endocrinol. 156: 1–6.

    Article  CAS  PubMed  Google Scholar 

  • Carey RM, Wang ZQ, Siragy HM, 2000, Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function. Hypertension. 35: 155–163.

    CAS  PubMed  Google Scholar 

  • Cesari M, Rossi GP, Pessina AC, 2002, Biological properties of the angiotensin peptides other than angiotensin II: implications for hypertension and cardiovascular diseases. J Hypertens. 20: 793–799.

    CAS  Google Scholar 

  • Chang MM, Leeman SE, Niall HD, 1971, Amino-acid sequence of substance P. Nat New Biol. 232: 86–87.

    CAS  PubMed  Google Scholar 

  • Chao J, Chao L, Swain CC, Tsai J, Margolius HS, 1987, Tissue kallikrein in rat brain and pituitary: regional distribution and estrogen induction in the anterior pituitary. Endocrinology. 120: 475–482.

    CAS  PubMed  Google Scholar 

  • Chappell MC, Brosnihan KB, Diz DI, Ferrario CM, 1989, Identification of angiotensin-(1-7) in rat brain. Evidence for differential processing of angiotensin peptides. J Biol Chem. 264: 16518–16523.

    CAS  PubMed  Google Scholar 

  • Chappell MC, Tallant EA, Brosnihan KB, Ferrario CM, 1990, Processing of angiotensin peptides by NG108-15 neuroblastoma x glioma hybrid cell line. Peptides. 11: 375–380.

    Article  CAS  PubMed  Google Scholar 

  • Chavkin C, James IF, Goldstein A, 1982, Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science. 215: 413–415.

    CAS  PubMed  Google Scholar 

  • Chen LX, Wang ZZ, Wu H, Fang Q, Chen Y, Wang R, 2002, Effects of nociceptin (13-17) in pain modulation at supraspinal level in mice. Neurosci Lett. 331: 95–98.

    CAS  PubMed  Google Scholar 

  • Chesneau V, Pierotti AR, Barre N, Creminon C, Tougard C, Cohen P, 1994, Isolation and characterization of a dibasic selective metalloendopeptidase from rat testes that cleaves at the amino terminus of arginine residues. J Biol Chem. 269: 2056–2061.

    CAS  PubMed  Google Scholar 

  • Chiba T, Yamaguchi A, Yamatani T, Nakamura A, Morishita T, Inui T, Fukase M, Noda T, Fujita T, 1989, Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37). Am J Physiol. 256: E331–335.

    Google Scholar 

  • Cooper JR, Bloom FE, Roth RH. 1996. Biochemical basis of neuropharmacology. New York Oxford University Press.

    Google Scholar 

  • Corbett AD, Paterson SJ, McKnight AT, Magnan J, Kosterlitz HW, 1982, Dynorphin and dynorphin are ligands for the kappa-subtype of opiate receptor. Nature. 299: 79–81.

    Article  CAS  PubMed  Google Scholar 

  • Couture R, Harrisson M, Vianna RM, Cloutier F, 2001, Kinin receptors in pain and inflammation. Eur J Pharmacol. 429: 161–176.

    Article  CAS  PubMed  Google Scholar 

  • Cridland RA, Henry JL, 1988, Effects of intrathecal administration of neuropeptides on a spinal nociceptive reflex in the rat: VIP, galanin, CGRP, TRH, somatostatin and angiotensin II. Neuropeptides. 11: 23–32.

    Article  CAS  PubMed  Google Scholar 

  • Day R, Lazure C, Basak A, Boudreault A, Limperis P, Dong W, Lindberg I, 1998, Prodynorphin processing by proprotein convertase 2. Cleavage at single basic residues and enhanced processing in the presence of carboxypeptidase activity. J Biol Chem. 273: 829–836.

    CAS  PubMed  Google Scholar 

  • De Araujo JE, Huston JP, Brandao ML, 2001, Opposite effects of substance P fragments C (anxiogenic) and N (anxiolytic) injected into dorsal periaqueductal gray. Eur J Pharmacol. 432: 43–51.

    PubMed  Google Scholar 

  • de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T, 2000, International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev. 52: 415–472.

    PubMed  Google Scholar 

  • Doggrell SA, 2001, Migraine and beyond: cardiovascular therapeutic potential for CGRP modulators. Expert Opin Investig Drugs. 10: 1131–1138.

    CAS  PubMed  Google Scholar 

  • Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, Acton S, 2000, A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res. 87: E1–9.

    Google Scholar 

  • Dornelles RC, Franci CR, 1998, Action of AT1 subtype angiotensin II receptors of the medial preoptic area on gonadotropins and prolactin release. Neuropeptides. 32: 51–55.

    Article  CAS  PubMed  Google Scholar 

  • Edvinsson L, 2003, New therapeutic target in primary headaches-blocking theCGRP receptor. Expert Opin Ther Targets. 7: 377–383.

    CAS  PubMed  Google Scholar 

  • Edvinsson L, Ekman R, Jansen I, Ottosson A, Uddman R, 1987, Peptide-containing nerve fibers in human cerebral arteries: immunocytochemistry, radioimmunoassay, and in vitro pharmacology. Ann Neurol. 21: 431–437.

    Article  CAS  PubMed  Google Scholar 

  • Eipper BA, Stoffers DA, Mains RE, 1992, The biosynthesis of neuropeptides: peptide alphaamidation. Annu Rev Neurosci. 15: 57–85.

    Article  CAS  PubMed  Google Scholar 

  • Flores CA, Wang XM, Zhang KM, Mokha SS, 2001, Orphanin FQ produces gender-specific modulation of trigeminal nociception: behavioral and electrophysiological observations. Neuroscience. 105: 489–498.

    Article  CAS  PubMed  Google Scholar 

  • Foulon T, Cadel S, Chesneau V, Draoui M, Prat A, Cohen P, 1996, Two novel metallopeptidases with a specificity for basic residues: functional properties, structure and cellular distribution. Ann N Y Acad Sci. 780: 106–120.

    CAS  PubMed  Google Scholar 

  • Freed AL, Audus KL, Lunte SM, 2001a, Investigation of the metabolism of substance P at the blood-brain barrier using capillary electrophoresis with laser-induced fluorescence detection. Electrophoresis. 22: 3778–3784.

    Article  CAS  PubMed  Google Scholar 

  • Freed AL, Cooper JD, Davies MI, Lunte SM, 2001b, Investigation of the metabolism of substance P in rat striatum by microdialysis sampling and capillary electrophoresis with laser-induced fluorescence detection. J Neurosci Methods. 109: 23–29.

    Article  CAS  PubMed  Google Scholar 

  • Flicker LD, Snyder SH, 1983, Purification and characterization of enkephalin convertase, an enkephalin-synthesizing carboxypeptidase. J Biol Chem. 258: 10950–10955.

    Google Scholar 

  • Garces YI, Rabito SF, Minshall RD, Sagen J, 1993, Lack of potent antinociceptive activity by substance P antagonist CP-96,345 in the rat spinal cord. Life Sci. 52: 353–360.

    Article  CAS  PubMed  Google Scholar 

  • Girgis SI, Macdonald DW, Stevenson JC, Bevis PJ, Lynch C, Wimalawansa SJ, Self CH, Morris HR, MacIntyre I, 1985, Calcitonin gene-related peptide: potent vasodilator and major product of calcitonin gene. Lancet. 2: 14–16.

    CAS  PubMed  Google Scholar 

  • Greene LJ, Spadaro AC, Martins AR, Perussi De Jesus WD, Camargo AC, 1982, Brain endooligopeptidase B: a post-proline cleaving enzyme that inactivates angiotensin I and II. Hypertension. 4: 178–184.

    CAS  PubMed  Google Scholar 

  • Griebel G, Perrault G, Sanger DJ, 1999, Orphanin FQ, a novel neuropeptide with anti-stresslike activity. Brain Res. 836: 221–224.

    Article  CAS  PubMed  Google Scholar 

  • Griswold JA, Beall CV, Baker CR, Jr., Little DT, Little GH, Behal FJ, 1996, Bradykinin metabolism in the liver and lung of the rat. J Surg Res. 66: 12–20.

    Article  CAS  PubMed  Google Scholar 

  • Hall JE, Guyton AC, Mizelle HL, 1990, Role of the renin-angiotensin system in control of sodium excretion and arterial pressure. Acta Physiol Scand Suppl. 591: 48–62.

    CAS  PubMed  Google Scholar 

  • Hall JM, 1992, Bradykinin receptors: pharmacological properties and biological roles. Pharmacol Ther. 56: 131–190.

    Article  CAS  PubMed  Google Scholar 

  • Hall KL, Venkateswaran S, Hanesworth JM, Schelling ME, Harding JW, 1995, Characterization of a functional angiotensin IV receptor on coronary microvascular endothelial cells. Regul Pept. 58: 107–115.

    Article  CAS  PubMed  Google Scholar 

  • Hallberg M, Nyberg F, 2003, Neuropeptide conversion to bioactive fragments—an important pathway in neuromodulation. Curr Protein Pept Sci. 4: 31–44.

    Article  CAS  PubMed  Google Scholar 

  • Harrison S, Geppetti P, 2001, Substance P. Int J Biochem Cell Biol. 33: 555–576.

    Article  CAS  PubMed  Google Scholar 

  • Hasumi K, Kobayashi S, Hazato T, Hase K, Kaya K, 1989, [A study of the leucine enkephalin like substance and enkephalin degrading enzyme activity in human cerebrospinal fluid]. Masui. 38: 1177–1180.

    CAS  PubMed  Google Scholar 

  • Hess JF, Borkowski JA, Young GS, Strader CD, Ransom RW, 1992, Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem Biophys Res Commun. 184: 260–268.

    Article  CAS  PubMed  Google Scholar 

  • Hess JF, Hey PJ, Chen TB, O’Brien J, Omalley SS, Pettibone DJ, Chang RS, 2001, Molecular cloning and pharmacological characterization of the canine B1 and B2 bradykinin receptors. Biol Chem. 382: 123–129.

    Article  CAS  PubMed  Google Scholar 

  • Hokfelt T, Castel M-N, Morino P, Zhang X, Dagerlind A. 1994. General overview of neuropeptides. In: Bloom FE, Kaplan DJ, Psychopharmacology: the fourth generation of progress. New York Raven Press.

    Google Scholar 

  • Hook VY, Schiller MR, Azaryan AV, 1996, The processing proteases prohormone thiol protease, PC1/3 and PC2, and 70-kDa aspartic proteinase show preferences among proenkephalin, proneuropeptide Y, and proopiomelanocortin substrates. Arch Biochem Biophys. 328: 107–114.

    Article  CAS  PubMed  Google Scholar 

  • Horvath G, 2000, Endomorphin-1 and endomorphin-2: pharmacology of the selective endogenous mu-opioid receptor agonists. Pharmacol Ther. 88: 437–463.

    Article  CAS  PubMed  Google Scholar 

  • Hughes J, Smith TW, Kosterlitz HW, Fothergill LA, Morgan BA, Morris HR, 1975, Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature. 258: 577–580.

    Article  CAS  PubMed  Google Scholar 

  • Hyyppa MT, Alaranta H, Lahtela K, Nykvist F, Hurme M, Nyberg F, Le Greves P, Sakurada T, Terenius L, 1990, Neuropeptide converting enzyme activities in CSF of low back pain patients. Pain. 43: 163–168.

    Article  CAS  PubMed  Google Scholar 

  • Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan BL, Inagami T, 1995, Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature. 377: 748–750.

    Article  CAS  PubMed  Google Scholar 

  • Inagaki S, Kito S, Kubota Y, Girgis S, Hillyard CJ, MacIntyre I, 1986, Autoradiographic localization of calcitonin gene-related peptide binding sites in human and rat brains. Brain Res. 374: 287–298.

    Article  CAS  PubMed  Google Scholar 

  • Inoue M, Matsunaga S, Rashid MH, Yoshida A, Mizuno K, Sakurada T, Takeshima H, Ueda H, 2001, Pronociceptive effects of nociceptin/orphanin FQ (13-17) at peripheral and spinal level in mice. J Pharmacol Exp Ther. 299: 213-219.

    Google Scholar 

  • Jackman HL, Massad MG, Sekosan M, Tan F, Brovkovych V, Marcic BM, Erdos EG, 2002, Angiotensin 1-9 and 1-7 release in human heart: role of cathepsin A. Hypertension. 39: 976–981.

    Article  CAS  PubMed  Google Scholar 

  • Johansson B, Holm M, Ewert S, Casselbrant A, Pettersson A, Fandriks L, 2001, Angiotensin II type 2 receptor-mediated duodenal mucosal alkaline secretion in the rat. Am J Physiol Gastrointest Liver Physiol. 280: G1254–1260.

    Google Scholar 

  • Jones DB, Mitchell D, Horn DB, Edwards CR, 1991, Cerebrospinal fluid angiotensin converting enzyme levels in the diagnosis of neurosarcoidosis. Scott Med J. 36: 144–145.

    CAS  PubMed  Google Scholar 

  • Jornvall H, 1975, Acetylation of Protein N-terminal amino groups structural observations on alpha-amino acetylated proteins. J Theor Biol. 55: 1–12.

    CAS  PubMed  Google Scholar 

  • Kakinuma Y, Hama H, Sugiyama F, Goto K, Murakami K, Fukamizu A, 1997, Antiapoptotic action of angiotensin fragments to neuronal cells from angiotensinogen knockout mice. Neurosci Lett. 232: 167–170.

    Article  CAS  PubMed  Google Scholar 

  • Kariya K, Yamauchi A, Sasaki T, 1985, Regional distribution and characterization of kinin in the CNS of the rat. J Neurochem. 44: 1892–1897.

    CAS  PubMed  Google Scholar 

  • Karlsson K, Eriksson U, Andren P, Nyberg F, 1997, Purification and characterization of substance P endopeptidase activities in the rat spinal cord. Prep Biochem Biotechnol. 27: 59–78.

    CAS  PubMed  Google Scholar 

  • Kask A, Harro J, von Horsten S, Redrobe JP, Dumont Y, Quirion R, 2002, The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci Biobehav Rev. 26: 259–283.

    Article  CAS  PubMed  Google Scholar 

  • Kastin AJ, Zadina JE, Olson RD, Banks WA, 1996, The history of neuropeptide research: version 5.a. Ann N Y Acad Sci. 780: 1–18.

    CAS  PubMed  Google Scholar 

  • Katopodis AG, Ping DS, Smith CE, May SW, 1991, Functional and structural characterization of peptidylamidoglycolate lyase, the enzyme catalyzing the second step in peptide amidation. Biochemistry. 30: 6189–6194.

    Article  CAS  PubMed  Google Scholar 

  • Kehoe PG, Katzov H, Feuk L, Bennet AM, Johansson B, Wiman B, de Faire U, Cairns NJ, Wilcock GK, Brookes AJ, Blennow K, Prince JA, 2003, Haplotypes extending across ACE are associated with Alzheimer’s disease. Hum Mol Genet. 12: 859–867.

    Article  CAS  PubMed  Google Scholar 

  • Koida M, Walter R, 1976, Post-proline cleaving enzyme. Purification of this endopeptidase by affinity chromatography. J Biol Chem. 251: 7593–7599.

    CAS  PubMed  Google Scholar 

  • Kokkonen JO, Kuoppala A, Saarinen J, Lindstedt KA, Kovanen PT, 1999, Kallidin-and bradykinin-degrading pathways in human heart: degradation of kallidin by aminopeptidase M-like activity and bradykinin by neutral endopeptidase. Circulation. 99: 1984–1990.

    CAS  PubMed  Google Scholar 

  • Koob GF, 1996, Drug addiction: the yin and yang of hedonic homeostasis. Neuron. 16: 893–896.

    Article  CAS  PubMed  Google Scholar 

  • Kramer MS, Cutler N, Feighner J, Shrivastava R, Carman J, Sramek JJ, Reines SA, Liu G, Snavely D, Wyatt-Knowles E, Hale JJ, Mills SG, MacCoss M, Swain CJ, Harrison T, Hill RG, Hefti F, Scolnick EM, Cascieri MA, Chicchi GG, Sadowski S, Williams AR, Hewson L, Smith D, Carlson EJ, Hargreaves RJ, Rupniak NM, 1998, Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science. 281: 1640–1645.

    Article  CAS  PubMed  Google Scholar 

  • Kurtz MM, Wang R, Clements MK, Cascieri MA, Austin CP, Cunningham BR, Chicchi GG, Liu Q, 2002, Identification, localization and receptor characterization of novel mammalian substance P-like peptides. Gene. 296: 205–212.

    Article  CAS  PubMed  Google Scholar 

  • Laflamme L, Gasparo M, Gallo JM, Payet MD, Gallo-Payet N, 1996, Angiotensin II induction of neurite outgrowth by AT2 receptors in NG108-15 cells. Effect counteracted by the AT1 receptors. J Biol Chem. 271: 22729–22735.

    CAS  PubMed  Google Scholar 

  • Laughlin TM, Vanderah TW, Lashbrook J, Nichols ML, Ossipov M, Porreca F, Wilcox GL, 1997, Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors. Pain. 72: 253–260.

    Article  CAS  PubMed  Google Scholar 

  • Le Greves P, Andersson K, Silberring J, 1997, Isolation and identification of CGRP Cterminal fragments in the rat spinal cord. Neuropeptides. 31: 19–23.

    PubMed  Google Scholar 

  • Le Greves P, Nyberg F, Hokfelt T, Terenius L, 1989, Calcitonin gene-related peptide is metabolized by an endopeptidase hydrolyzing substance P. Regul Pept. 25: 277–286.

    PubMed  Google Scholar 

  • Le Greves P, Nyberg F, Terenius L, Hokfelt T, 1985, Calcitonin gene-related peptide is a potent inhibitor of substance P degradation. Eur J Pharmacol. 115: 309–311.

    PubMed  Google Scholar 

  • Lee J, Chai SY, Mendelsohn FA, Morris MJ, Allen AM, 2001, Potentiation of cholinergic transmission in the rat hippocampus by angiotensin IV and LVV-hemorphin-7. Neuropharmacology. 40: 618–623.

    Article  CAS  PubMed  Google Scholar 

  • Lembeck F, Folkers K, Donnerer J, 1981, Analgesic effect of antagonists of substance P. Biochem Biophys Res Commun. 103: 1318–1321.

    CAS  PubMed  Google Scholar 

  • Lembeck F, Holzer P, 1979, Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn Schmiedebergs Arch Pharmacol. 310: 175–183.

    Article  CAS  PubMed  Google Scholar 

  • Levine JD, Dardick SJ, Roizen MF, Helms C, Basbaum AI, 1986, Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis. J Neurosci. 6: 3423–3429.

    CAS  PubMed  Google Scholar 

  • Liu Z, Lyrenas S, Thornwall M, Le Greves P, Nyberg F, 1997, Elevated cerebrospinal fluid level of substance P and decreased undecapeptidase activity at term pregnancy. Neuropeptides. 31: 415–421.

    Article  CAS  PubMed  Google Scholar 

  • Loh YP, 1987, Peptide precursor processing enzymes within secretory vesicles. Ann N Y Acad Sci. 493:292–307.

    CAS  PubMed  Google Scholar 

  • Loh YP, Cawley NX, 1995, Processing enzymes of pepsin family: yeast aspartic protease 3 and pro-opiomelanocortin converting enzyme. Methods Enzymol. 248: 136–146.

    CAS  PubMed  Google Scholar 

  • Lowe JA, 3rd, Drozda SE, Snider RM, Longo KP, Zorn SH, Jackson ER, Morrone J, McLean S, Bryce DK, Bordner J, Nagahisa A, Kanai Y, Suga O, Tsuchiya M, 1993, Discovery of CP-96,345 and its characterization in disease models involving substance P. Regul Pept. 46: 20–23.

    Article  CAS  PubMed  Google Scholar 

  • Lucius R, Gallinat S, Rosenstiel P, Herdegen T, Sievers J, Unger T, 1998, The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats. J Exp Med. 188: 661–670.

    Article  CAS  PubMed  Google Scholar 

  • Ludwig R, Feindt J, Lucius R, Petersen A, Mentlein R, 1996, Metabolism of neuropeptide Y and calcitonin gene-related peptide by cultivated neurons and glial cells. Brain Res Mol Brain Res. 37: 181–191.

    CAS  PubMed  Google Scholar 

  • Lyrenas S, Nyberg F, Lindberg B, Ternius L, 1988, Cerebrospinal fluid activity of dynorphin-converting enzyme at term pregnancy. Obstet Gynecol. 72: 54–58.

    CAS  PubMed  Google Scholar 

  • Maggi CA, Rovero P, Giuliani S, Evangelista S, Regoli D, Meli A, 1990, Biological activity of N-terminal fragments of calcitonin gene-related peptide. Eur J Pharmacol. 179: 217–219.

    Article  CAS  PubMed  Google Scholar 

  • Manabe T, Noda Y, Mamiya T, Katagiri H, Houtani T, Nishi M, Noda T, Takahashi T, Sugimoto T, Nabeshima T, Takeshima H, 1998, Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature. 394: 577–581.

    CAS  PubMed  Google Scholar 

  • Mantyh CR, Gates TS, Zimmerman RP, Welton ML, Passaro EP, Jr., Vigna SR, Maggio JE, Kruger L, Mantyh PW, 1988, Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease. Proc Natl Acad Sci U S A. 85: 3235–3239.

    CAS  PubMed  Google Scholar 

  • Mao J, Coghill RC, Kellstein DE, Frenk H, Mayer DJ, 1992, Calcitonin gene-related peptide enhances substance P-induced behaviors via metabolic inhibition: in vivo evidence for a new mechanism of neuromodulation. Brain Res. 574: 157–163.

    Article  CAS  PubMed  Google Scholar 

  • Masaki H, Kurihara T, Yamaki A, Inomata N, Nozawa Y, Mori Y, Murasawa S, Kizima K, Maruyama K, Horiuchi M, Dzau VJ, Takahashi H, Iwasaka T, Inada M, Matsubara H, 1998, Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects. J Clin Invest. 101: 527–535.

    CAS  PubMed  Google Scholar 

  • Matsas R, Fulcher IS, Kenny AJ, Turner AJ, 1983, Substance P and [Leu]enkephalin are hydrolyzed by an enzyme in pig caudate synaptic membranes that is identical with the endopeptidase of kidney microvilli. Proc Natl Acad Sci U S A. 80: 3111–3115.

    CAS  PubMed  Google Scholar 

  • McEachern AE, Shelton ER, Bhakta S, Obernolte R, Bach C, Zuppan P, Fujisaki J, Aldrich RW, Jarnagin K, 1991, Expression cloning of a rat B2 bradykinin receptor. Proc Natl Acad Sci U S A. 88: 7724–7728.

    CAS  PubMed  Google Scholar 

  • Medeiros Mdos S, Turner AJ, 1996, Metabolism and functions of neuropeptide Y. Neurochem Res. 21: 1125–1132.

    PubMed  Google Scholar 

  • Meffert S, Stoll M, Steckelings UM, Bottari SP, Unger T, 1996, The angiotensin II AT2 receptor inhibits proliferation and promotes differentiation in PC12W cells. Mol Cell Endocrinol. 122: 59–67.

    Article  CAS  PubMed  Google Scholar 

  • Menke JG, Borkowski JA, Bierilo KK, MacNeil T, Derrick AW, Schneck KA, Ransom RW, Strader CD, Linemeyer DL, Hess JF, 1994, Expression cloning of a human B1 bradykinin receptor. J Biol Chem. 269: 21583–21586.

    CAS  PubMed  Google Scholar 

  • Mentlein R, Dahms P, Grandt D, Kruger R, 1993, Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV. Regul Pept. 49: 133–144.

    Article  CAS  PubMed  Google Scholar 

  • Mentlein R, Roos T, 1996, Proteases involved in the metabolism of angiotensin II, bradykinin, calcitonin gene-related peptide (CGRP), and neuropeptide Y by vascular smooth muscle cells. Peptides. 17: 709–720.

    Article  CAS  PubMed  Google Scholar 

  • Meunier JC, 1997, Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor. Eur J Pharmacol. 340: 1–15.

    Article  CAS  PubMed  Google Scholar 

  • Meunier JC, Mollereau C, Toll L, Suaudeau C, Moisand C, Alvinerie P, Butour JL, Guillemot JC, Ferrara P, Monsarrat B, Mazarguil H, Vassart G, Parmentier M, Costentin J, 1995, Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 377: 532–535.

    Article  CAS  PubMed  Google Scholar 

  • Michaud JC, Alonso R, Gueudet C, Fournier M, Calassi R, Breliere JC, Le Fur G, Soubrie P, 1998, Effects of SR140333, a selective non-peptide NK1 receptor antagonist, on trigemino-thalamic nociceptive pathways in the rat. Fundam Clin Pharmacol. 12: 88–94.

    CAS  PubMed  Google Scholar 

  • Michel MC, Beck-Sickinger A, Cox H, Doods HN, Herzog H, Larhammar D, Quirion R, Schwartz T, Westfall T, 1998, XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev. 50: 143–150.

    CAS  PubMed  Google Scholar 

  • Mimeault M, Quirion R, Dumont Y, St-Pierre S, Fournier A, 1992, Structure-activity study of hCGRP8-37, a calcitonin gene-related peptide receptor antagonist. J Med Chem. 35: 2163–2168.

    Article  CAS  PubMed  Google Scholar 

  • Minth CD, Bloom SR, Polak JM, Dixon JE, 1984, Cloning, characterization, and DNA sequence of a human cDNA encoding neuropeptide tyrosine. Proc Natl Acad Sci U S A. 81:4577–4581.

    CAS  PubMed  Google Scholar 

  • Montiel JL, Cornille F, Roques BP, Noble F, 1997, Nociceptin/orphanin FQ metabolism: role of aminopeptidase and endopeptidase 24.15. J Neurochem. 68: 354–361.

    CAS  PubMed  Google Scholar 

  • Moreau C, Rasolonjanahary R, Audinot V, Kordon C, Enjalbert A, 1994, Angiotensin II effects on second messengers involved in prolactin secretion are mediated by AT1 receptor in anterior pituitary cells. Mol Cell Neurosci. 5: 597–603.

    Article  CAS  PubMed  Google Scholar 

  • Mousa SA, Shakibaei M, Sitte N, Schafer M, Stein C, 2004, Subcellular pathways of betaendorphin synthesis, processing, and release from immunocytes in inflammatory pain. Endocrinology. 145: 1331–1341.

    CAS  PubMed  Google Scholar 

  • Mukoyama M, Nakajima M, Horiuchi M, Sasamura H, Pratt RE, Dzau VJ, 1993, Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem. 268: 24539–24542.

    CAS  PubMed  Google Scholar 

  • Mulderry PK, Ghatei MA, Rodrigo J, Allen JM, Rosenfeld MG, Polak JM, Bloom SR, 1985, Calcitonin gene-related peptide in cardiovascular tissues of the rat. Neuroscience. 14: 947–954.

    Article  CAS  PubMed  Google Scholar 

  • Muraki K, Nakata Y, Simonaka H, Inoue J, Hirai Y, Akiyama M, 1996, Neutral endopeptidase activity in serum and cerebrospinal fluid. Hiroshima J Med Sci. 45: 109–112.

    CAS  PubMed  Google Scholar 

  • Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE, 1991, Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature. 351: 233–236.

    CAS  PubMed  Google Scholar 

  • Nagase T, Miyajima N, Tanaka A, Sazuka T, Seki N, Sato S, Tabata S, Ishikawa K, Kawarabayasi Y, Kotani H, Nomura N, 1995, Prediction of the coding sequences of unidentified human genes. III. The coding sequences of 40 new genes (KIAA0081-KIAA0120) deduced by analysis of cDNA clones from human cell line KG-1. DNA Res. 2: 37–43.

    CAS  PubMed  Google Scholar 

  • Navari RM, Reinhardt RR, Gralla RJ, Kris MG, Hesketh PJ, Khojasteh A, Kindler H, Grote TH, Pendergrass K, Grunberg SM, Carides AD, Gertz BJ, 1999, Reduction of cisplatininduced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group. N Engl J Med. 340: 190–195.

    Article  CAS  PubMed  Google Scholar 

  • Neal CR, Jr., Mansour A, Reinscheid R, Nothacker HP, Civelli O, Watson SJ, Jr., 1999, Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J Comp Neurol. 406: 503–547.

    Article  CAS  PubMed  Google Scholar 

  • Nohr D, Schafer MK, Persson S, Romeo H, Nyberg F, Post C, Ekstrom G, Weihe E, 1999, Calcitonin gene-related peptide gene expression in collagen-induced arthritis is differentially regulated in primary afferents and motoneurons: influence of glucocorticoids. Neuroscience. 93: 759–773.

    Article  CAS  PubMed  Google Scholar 

  • Nyberg F, Lieberman H, Lindstrom LH, Lyrenas S, Koch G, Terenius L, 1989, Immunoreactive beta-casomorphin-8 in cerebrospinal fluid from pregnant and lactating women: correlation with plasma levels. J Clin Endocrinol Metab. 68: 283–289.

    CAS  PubMed  Google Scholar 

  • Nyberg F, Nordstrom K, Terenius L, 1985, Endopeptidase in human cerebrospinal fluid which cleaves proenkephalin B opioid peptides at consecutive basic amino acids. Biochem Biophys Res Commun. 131: 1069–1074.

    Article  CAS  PubMed  Google Scholar 

  • Nyberg F, Sanderson K, Glamsta EL, 1997, The hemorphins: a new class of opioid peptides derived from the blood protein hemoglobin. Biopolymers. 43: 147–156.

    Article  CAS  PubMed  Google Scholar 

  • Nyberg F, Silberring J, 1990, Conversion of the dynorphins to Leu-enkephalin in human spinal cord. Prog Clin Biol Res. 328: 261–265.

    CAS  PubMed  Google Scholar 

  • Nyberg F, Terenius L. 1991. Enzymatic inactivation of neuropeptides. In: Henriksen JH, Degradation of Bioactive Substances, Physiology and Pathophysiology. New York CRC Press Inc.

    Google Scholar 

  • Orlowski M, Wilk E, Pearce S, Wilk S, 1979, Purification and properties of a prolyl endopeptidase from rabbit brain. J Neurochem. 33: 461–469.

    CAS  PubMed  Google Scholar 

  • Page NM, Bell NJ, Gardiner SM, Manyonda IT, Brayley KJ, Strange PG, Lowry PJ, 2003, Characterization of the endokinins: human tachykinins with cardiovascular activity. Proc Natl Acad Sci U S A. 100: 6245–6250.

    Article  CAS  PubMed  Google Scholar 

  • Parker E, Van Heek M, Stamford A, 2002, Neuropeptide Y receptors as targets for antiobesity drug development: perspective and current status. Eur J Pharmacol. 440: 173–187.

    Article  CAS  PubMed  Google Scholar 

  • Pederson ES, Krishnan R, Harding JW, Wright JW, 2001, A role for the angiotensin AT4 receptor subtype in overcoming scopolamine-induced spatial memory deficits. Regul Pept. 102: 147–156.

    Article  CAS  PubMed  Google Scholar 

  • Persson S, Le Greves P, Thornwall M, Eriksson U, Silberring J, Nyberg F, 1995, Neuropeptide converting and processing enzymes in the spinal cord and cerebrospinal fluid. Prog Brain Res. 104: 111–130.

    CAS  PubMed  Google Scholar 

  • Persson S, Post C, Alari L, Nyberg F, Terenius L, 1989, Increased neuropeptide-converting enzyme activities in cerebrospinal fluid of opiate-tolerant rats. Neurosci Lett. 107: 318–322.

    Article  CAS  PubMed  Google Scholar 

  • Persson S, Post C, Holmdahl R, Nyberg F, 1992a, Decreased neuropeptide-converting enzyme activities in cerebrospinal fluid during acute but not chronic phases of collagen induced arthritis in rats. Brain Res. 581: 273–282.

    Article  CAS  PubMed  Google Scholar 

  • Persson S, Post C, Weil-Fugazza J, Butler SH, Nyberg F, 1992b, Decreased cerebrospinal fluid neuropeptide-converting enzyme activity in monoarthritic rats. Neurosci Lett. 143: 247–250.

    Article  CAS  PubMed  Google Scholar 

  • Petrov VV, Fagard RH, Lijnen PJ, 2004, Arginine-aminopeptidase in rat cardiac fibroblastic cells participates in angiotensin peptide turnover. Cardiovasc Res. 61: 724–735.

    Article  CAS  PubMed  Google Scholar 

  • Redrobe JP, Dumont Y, Fournier A, Quirion R, 2002, The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test. Neuropsychopharmacology. 26: 615–624.

    Article  CAS  PubMed  Google Scholar 

  • Reed B, Zhang Y, Chait BT, Kreek MJ, 2003, Dynorphin A(1-17) biotransformation in striatum of freely moving rats using microdialysis and matrix-assisted laser desorption/ionization mass spectrometry. J Neurochem. 86: 815–823.

    Article  CAS  PubMed  Google Scholar 

  • Regoli D, Barabe J, 1980, Pharmacology of bradykinin and related kinins. Pharmacol Rev. 32: 1–46.

    CAS  PubMed  Google Scholar 

  • Reinscheid R, Civelli O, 2002, The orphanin FQ/nociceptin knockout mouse: A behavioral model for stress responses. neuropeptides. 36: 72.

    Google Scholar 

  • Reinscheid RK, Nothacker HP, Bourson A, Ardati A, Henningsen RA, Bunzow JR, Grandy DK, Langen H, Monsma FJ, Jr., Civelli O, 1995, Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science. 270: 792–794.

    CAS  PubMed  Google Scholar 

  • Rimon R, Le Greves P, Nyberg F, Heikkila L, Salmela L, Terenius L, 1984, Elevation of substance P-like peptides in the CSF of psychiatric patients. Biol Psychiatry. 19: 509–516.

    CAS  PubMed  Google Scholar 

  • Robertson MJ, Cunoosamy MP, Clark KL, 1992, Effects of peptidase inhibition on angiotensin receptor agonist and antagonist potency in rabbit isolated thoracic aorta. Br J Pharmacol. 106: 166–172.

    CAS  PubMed  Google Scholar 

  • Roh J, Chang CL, Bhalla A, Klein C, Hsu SY, 2004, Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes. J Biol Chem. 279: 7264–7274.

    Article  CAS  PubMed  Google Scholar 

  • Roques BP, Noble F, Dauge V, Fournie-Zaluski MC, Beaumont A, 1993, Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev. 45: 87–146.

    CAS  PubMed  Google Scholar 

  • Rosenbaum C, Cardozo C, Lesser M, 1995, Degradation of lysylbradykinin by endopeptidase 24.11 and endopeptidase 24.15. Peptides. 16: 523–525.

    Article  CAS  PubMed  Google Scholar 

  • Rosenfeld MG, Amara SG, Roos BA, Ong ES, Evans RM, 1981, Altered expression of the calcitonin gene associated with RNA polymorphism. Nature. 290: 63–65.

    Article  CAS  PubMed  Google Scholar 

  • Rosenfeld MG, Mermod JJ, Amara SG, Swanson LW, Sawchenko PE, Rivier J, Vale WW, Evans RM, 1983, Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature. 304: 129–135.

    Article  CAS  PubMed  Google Scholar 

  • Rossi GC, Leventhal L, Bolan E, Pasternak GW, 1997, Pharmacological characterization of orphanin FQ/nociceptin and its fragments. J Pharmacol Exp Ther. 282: 858–865.

    CAS  PubMed  Google Scholar 

  • Rovero P, Giuliani S, Maggi CA, 1992, CGRP antagonist activity of short C-terminal fragments of human alpha CGRP, CGRP(23-37) and CGRP(19-37). Peptides. 13: 1025–1027.

    Article  CAS  PubMed  Google Scholar 

  • Ryan JW, 1989, Peptidase enzymes of the pulmonary vascular surface. Am J Physiol. 257: L53–60.

    Google Scholar 

  • Sahu A, Kalra PS, Kalra SP, 1988, Food deprivation and ingestion induce reciprocal changes in neuropeptide Y concentrations in the paraventricular nucleus. Peptides. 9: 83–86.

    CAS  PubMed  Google Scholar 

  • Sainsbury A, Schwarzer C, Couzens M, Herzog H, 2002, Y2 receptor deletion attenuates the type 2 diabetic syndrome of ob/ob mice. Diabetes. 51: 3420–3427.

    CAS  PubMed  Google Scholar 

  • Sakurada C, Sakurada S, Orito T, Tan-No K, Sakurada T, 2002, Degradation of nociceptin (orphanin FQ) by mouse spinal cord synaptic membranes is triggered by endopeptidase-24.11: an in vitro and in vivo study. Biochem Pharmacol. 64: 1293–1303.

    Article  CAS  PubMed  Google Scholar 

  • Sakurada C, Watanabe C, Sakurada T, 2004, Occurrence of substance P( 1-7) in the metabolism of substance P and its antinociceptive activity at the mouse spinal cord level. Methods Find Exp Clin Pharmacol. 26: 171–176.

    Article  CAS  PubMed  Google Scholar 

  • Sakurada T, Le Greves P, Stewart J, Terenius L, 1985, Measurement of substance P metabolites in rat CNS. J Neurochem. 44: 718–722.

    CAS  PubMed  Google Scholar 

  • Sakurada T, Le Greves P, Terenius L, 1991, Fragmentation of Calcitonin gene-related peptide and substance P in the rat central nervous system. Netuochem Int. 19: 341–347.

    CAS  Google Scholar 

  • Sakurada T, Sakurada S, Katsuyama S, Hayashi T, Sakurada C, Tan-No K, Johansson H, Sandin J, Terenius L, 2000, Evidence that N-terminal fragments of nociceptin modulate nociceptin-induced scratching, biting and licking in mice. Neurosci Lett. 279: 61–64.

    Article  CAS  PubMed  Google Scholar 

  • Sandin J, Georgieva J, Schott PA, Ogren SO, Terenius L, 1997, Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats. Eur J Neurosci. 9: 194–197.

    CAS  PubMed  Google Scholar 

  • Sandin J, Georgieva J, Silberring J, Terenius L, 1999, In vivo metabolism of nociceptin/orphanin FQ in rat hippocampus. Neuroreport. 10: 71–76.

    CAS  PubMed  Google Scholar 

  • Seidah NG, Chretien M, 1999, Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides. Brain Res. 848: 45–62.

    Article  CAS  PubMed  Google Scholar 

  • Seizinger BR, Hollt V, Herz A, 1984, Proenkephalin B (prodynorphin)-derived opioid peptides: evidence for a differential processing in lobes of the pituitary. Endocrinology. 115:662–671.

    CAS  PubMed  Google Scholar 

  • Severini C, Improta G, Falconieri-Erspamer G, Salvadori S, Erspamer V, 2002, The tachykinin Peptide family. Pharmacol Rev. 54: 285–322.

    Article  CAS  PubMed  Google Scholar 

  • Silberring J, Castello ME, Nyberg F, 1992a, Characterization of dynorphin A-converting enzyme in human spinal cord. An endoprotease related to a distinct conversion pathway for the opioid heptadecapeptide? J Biol Chem. 267: 21324–21328.

    CAS  PubMed  Google Scholar 

  • Silberring J, Nyberg F, 1989, A novel bovine spinal cord endoprotease with high specificity for dynorphin B. J Biol Chem. 264: 11082–11086.

    CAS  PubMed  Google Scholar 

  • Silberring J, Sakurada T, Nyberg F, 1992b, Dynorphin converting enzyme in the rat spinal cord. Decreased activities during acute phase of adjuvant induced arthritis. Life Sci. 50: 839–847.

    Article  CAS  PubMed  Google Scholar 

  • Silva AP, Cavadas C, Grouzmann E, 2002, Neuropeptide Y and its receptors as potential therapeutic drug targets. Clin Chim Acta. 326: 3–25.

    Article  CAS  PubMed  Google Scholar 

  • Skidgel RA, 1992, Bradykinin-degrading enzymes: structure, function, distribution, and potential roles in cardiovascular pharmacology. J Cardiovasc Pharmacol. 20 Suppl 9: S4–9.

    Google Scholar 

  • Skidgel RA, Engelbrecht S, Johnson AR, Erdos EG, 1984, Hydrolysis of substance p and neurotensin by converting enzyme and neutral endopeptidase. Peptides. 5: 769–776.

    Article  CAS  PubMed  Google Scholar 

  • Stenfors C, Hellman U, Silberring J, 1997, Characterization of endogenous neuropeptide Y in rat hippocampus and its metabolism by nanospray mass spectrometry. J Biol Chem. 272: 5747–5751.

    CAS  PubMed  Google Scholar 

  • Struthers AD, Brown MJ, Macdonald DW, Beacham JL, Stevenson JC, Morris HR, MacIntyre I, 1986, Human calcitonin gene related peptide: a potent endogenous vasodilator in man. Clin Sci (Lond). 70: 389–393.

    CAS  Google Scholar 

  • Taiwo OB, Taylor BK, 2002, Antihyperalgesic effects of intrathecal neuropeptide Y during inflammation are mediated by Y1 receptors. Pain. 96: 353–363.

    Article  CAS  PubMed  Google Scholar 

  • Tatemoto K, Carlquist M, Mutt V, 1982, Neuropeptide Y—a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature. 296: 659–660.

    Article  CAS  PubMed  Google Scholar 

  • Taylor A, 1993, Aminopeptidases: towards a mechanism of action. Trends Biochem Sci. 18: 167–171.

    Article  CAS  PubMed  Google Scholar 

  • Tebbs C, Pratten MK, Broughton Pipkin F, 1999, Angiotensin II is a growth factor in the peri-implantation rat embryo. J Anat. 195: 75–86.

    Article  CAS  PubMed  Google Scholar 

  • Terenius L, Sandin J, Sakurada T, 2000, Nociceptin/orphanin FQ metabolism and bioactive metabolites. Peptides. 21: 919–922.

    Article  CAS  PubMed  Google Scholar 

  • Thiele TE, Koh MT, Pedrazzini T, 2002, Voluntary alcohol consumption is controlled via the neuropeptide Y Y1 receptor. J Neurosci. 22: RC208.

    Google Scholar 

  • Thorsell A, Rimondini R, Heilig M, 2002, Blockade of central neuropeptide Y (NPY) Y2 receptors reduces ethanol self-administration in rats. Neurosci Lett. 332: 1–4.

    Article  CAS  PubMed  Google Scholar 

  • Vaghy PL, Russell JS, Lantry LE, Stephens RE, Ward PE, 1995, Angiotensin and bradykinin metabolism by peptidases identified in cultured human skeletal muscle myocytes and fibroblasts. Peptides. 16: 1367–1373.

    Article  CAS  PubMed  Google Scholar 

  • Vettor R, Zarjevski N, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B, 1994, Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats. Diabetologia. 37: 1202–1208.

    CAS  PubMed  Google Scholar 

  • Wagner JJ, Chauvkin C. 1995. Neuropharmacology of endogenous opioid peptides. New York Raven Press.

    Google Scholar 

  • Watanabe Y, Kojima-Komatsu T, Iwaki-Egawa S, Fujimoto Y, 1993, Increased excretion of proline-containing peptides in dipeptidyl peptidase IV-deficient rats. Res Commun Chem Pathol Pharmacol. 81: 323–330.

    CAS  PubMed  Google Scholar 

  • Weihe E, Nohr D, Schafer MK, Persson S, Ekstrom G, Kallstrom J, Nyberg F, Post C, 1995, Calcitonin gene related peptide gene expression in collagen-induced arthritis. Can J Physiol Pharmacol. 73: 1015–1019.

    CAS  PubMed  Google Scholar 

  • Welches WR, Santos RA, Chappell MC, Brosnihan KB, Greene LJ, Ferrario CM, 1991, Evidence that prolyl endopeptidase participates in the processing of brain angiotensin. J Hypertens. 9: 631–638.

    CAS  PubMed  Google Scholar 

  • Wright JW, Harding JW, 1997, Important role for angiotensin III and IV in the brain reninangiotensin system. Brain Res Brain Res Rev. 25: 96–124.

    Article  CAS  PubMed  Google Scholar 

  • Wright JW, Miller-Wing AV, Shaffer MJ, Higginson C, Wright DE, Hanesworth JM, Harding JW, 1993, Angiotensin II(3-8) (ANG IV) hippocampal binding: potential role in the facilitation of memory. Brain Res Bull. 32: 497–502.

    Article  CAS  PubMed  Google Scholar 

  • Yamamoto K, Chappell MC, Brosnihan KB, Ferrario CM, 1992, In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats. Hypertension. 19: 692–696.

    CAS  PubMed  Google Scholar 

  • Yang HY, Erdos EG, Chiang TS, 1968, New enzymatic route for the inactivation of angiotensin. Nature. 218: 1224–1226.

    CAS  PubMed  Google Scholar 

  • Yokosawa H, Endo S, Ogura Y, Ishii S, 1983, A new feature of angiotensin-converting enzyme in the brain: hydrolysis of substance P. Biochem Biophys Res Commun. 116: 735–742.

    CAS  PubMed  Google Scholar 

  • Yu J, Chait BT, Toll L, Kreek MJ, 1996, Nociceptin in vitro biotransformation in human blood. Peptides. 17: 873–876.

    Article  CAS  PubMed  Google Scholar 

  • Zadina JE, Hackler L, Ge LJ, Kastin AJ, 1997, A potent and selective endogenous agonist for the mu-opiate receptor. Nature. 386: 499–502.

    Article  CAS  PubMed  Google Scholar 

  • Zaidi M, Brain SD, Tippins JR, Di Marzo V, Moonga BS, Chambers TJ, Morris HR, MacIntyre I, 1990, Structure-activity relationship of human calcitonin-gene-related peptide. Biochem J. 269: 775–780.

    CAS  PubMed  Google Scholar 

  • Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B, 1993, Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology. 133: 1753–1758

    Article  CAS  PubMed  Google Scholar 

  • Zhang Y, Lu L, Furlonger C, Wu GE, Paige CJ, 2000, Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis. Nat Immunol. 1: 392–397.

    Article  CAS  PubMed  Google Scholar 

  • Zhou Q, Karlsson K, Liu Z, Johansson P, Le Greves M, Kiuru A, Nyberg F, 2001, Substance P endopeptidase-like activity is altered in various regions of the rat central nervous system during morphine tolerance and withdrawal. Neuropharmacology. 41: 246–253.

    CAS  PubMed  Google Scholar 

  • Zhou Q, Liu Z, Ray A, Huang W, Karlsson K, Nyberg F, 1998, Alteration in the brain content of substance P (1-7) during withdrawal in morphine-dependent rats. Neuropharmacology. 37: 1545–1552.

    Article  CAS  PubMed  Google Scholar 

  • Zubrzycka M, Janecka A, 2000, Substance P: transmitter of nociception (Minireview). Endocr Regul. 34: 195–201.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Biosciences, Division of Biological Research on Drug Dependence, Uppsala University, Biomedical Center Box 591, 751 24, Uppsala, Sweden

    Mathias Hallberg, Pierre Le Grevès & Fred Nyberg

Authors
  1. Mathias Hallberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pierre Le Grevès
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fred Nyberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Otto-von-Guericke University, Magdeburg, Germany

    Uwe Lendeckel

  2. University of Leeds, Leeds, UK

    Nigel M. Hooper

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science + Business Media, Inc. Dordrecht

About this chapter

Cite this chapter

Hallberg, M., Le Grevès, P., Nyberg, F. (2005). Neuropeptide Processing. In: Lendeckel, U., Hooper, N.M. (eds) Proteases In The Brain. Proteases In Biology and Disease, vol 3. Springer, Boston, MA. https://doi.org/10.1007/0-387-23101-3_9

Download citation

Publish with us

Policies and ethics

Search

Navigation